Fluoronaphthalene - CAS 321-38-0
Catalog: |
BB021199 |
Product Name: |
Fluoronaphthalene |
CAS: |
321-38-0 |
Synonyms: |
Naphthalene, 1-fluoro-; 1-Fluoronaphthalene; NSC 4690; α-Fluoronaphthalene; Duloxetine USP Impurity G; Duloxetine EP Impurity G |
IUPAC Name: | 1-fluoronaphthalene |
Description: | An impurity of Duloxetine, which is a serotonin-norepinephrine reuptake inhibitor used for major depressive disorder, generalized anxiety disorder, fibromyalgia, and neuropathic pain. |
Molecular Weight: | 146.16 |
Molecular Formula: | C10H7F |
Canonical SMILES: | C1=CC=C2C(=C1)C=CC=C2F |
InChI: | InChI=1S/C10H7F/c11-10-7-3-5-8-4-1-2-6-9(8)10/h1-7H |
InChI Key: | CWLKTJOTWITYSI-UHFFFAOYSA-N |
Boiling Point: | 215°C |
Melting Point: | -9°C |
Purity: | ≥95% |
Density: | 1.1339 g/cm3 |
Solubility: | Soluble in Chloroform, Ethyl Acetate, Methanol (Sparingly) |
Appearance: | Colourless to Yellow Oily Liquid |
Storage: | Store at 2-8°C |
MDL: | MFCD00003873 |
LogP: | 2.97890 |
Vapor Pressure: | 0.09 [mmHg] |
Precautionary Statement: | P261-P305P351P338 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113429380-A | Preparation method of duloxetine | 20210714 |
CN-113512064-A | Preparation method of aromatic phosphine oxide compound | 20210430 |
CN-113072466-A | Synthetic method of dapoxetine impurity | 20210401 |
CN-112920727-A | High-temperature-resistant acrylic protective film with excellent air release property and preparation method thereof | 20210205 |
CN-113054107-A | Organic solution combination for coating organic solar cell | 20210205 |
PMID | Publication Date | Title | Journal |
22060730 | 20111222 | Intermolecular vibrations and diffusive orientational dynamics of Cs condensed ring aromatic molecular liquids | The journal of physical chemistry. A |
18035588 | 20081001 | Density functional theory study of vibrational spectra, and assignment of fundamental vibrational modes of 1-bromo 4-fluoronaphthalene | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy |
18752960 | 20080915 | Design and synthesis of 6-fluoro-2-naphthyl derivatives as novel CCR3 antagonists with reduced CYP2D6 inhibition | Bioorganic & medicinal chemistry |
21201896 | 20080206 | N,N-Dimethyl-3-(1-naphth-yloxy)-3-(2-thien-yl)propan-1-amine | Acta crystallographica. Section E, Structure reports online |
15809969 | 20050701 | Characterization of monofluorinated polycyclic aromatic compounds by 1H, 13C and 19F NMR spectroscopy | Magnetic resonance in chemistry : MRC |
Complexity: | 133 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 146.053178385 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 146.053178385 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 0 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Fluorinated Building Blocks
Halides
Other Pyrimidines
Customers Also Viewed
-
[94086-78-9]
Isopropyl 4-[4-[N,N-bis(2-hydroxyethyl)amino]phenyl]butyrate
-
[597-35-3]
ethylsulfone
-
[1118-71-4]
2,2,6,6-Tetramethyl-3,5-heptanedione
-
[104517-96-6]
Ioversol related compound B
-
[56507-37-0]
Metribuzin-diketo
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
INDUSTRY LEADERS TRUST OUR PRODUCTS